93
Participants
Start Date
June 30, 2011
Primary Completion Date
September 12, 2016
Study Completion Date
September 12, 2016
Cisplatin, Gemcitabine, Panitumumab
Cisplatin 25mq/sq.m. at day 1+8 and Gemcitabine 1000mg/sq.m. at day 1 + 8 Panitumumab 9mg/kg BW at day 1
Cisplatin, Gemcitabine
Cisplatin 25mq/sq.m. at day 1+8 and Gemcitabine 1000mg/sq.m. at day 1 + 8
Charité Berlin, Berlin
University Hospital Hamburg-Eppendorf, Hamburg
Medical School Hannover, Hanover
University Hospital Marburg, Marburg
Magdeburg Hospital, Magdeburg
University Hospital Essen, Essen
University Hospital Köln, Cologne
University Hospital Mainz, Mainz
University Hospital Mannheim, Mannheim
National Centre for Tumor Diseases (NCT), Heidelberg
University Hospital Tuebingen, Tübingen
Kreiskliniken Reutlingen GmbH, Reutlingen
Esslingen Hospital, Esslingen am Neckar
University Hospital Freiburg, Freiburg im Breisgau
Klinikum rechts der Isar der TU München, München
University Hospital Regensburg, Regensburg
Hannover Medical School
OTHER